Skip to main content
PeopleBio, Inc. logo

PeopleBio, Inc. — Investor Relations & Filings

Ticker · 304840 ISIN · KR7304840002 KO Manufacturing
Open in API
Filings indexed 250 across all filing types
Latest filing 2022-03-11 AGM Information
Country KR South Korea
Listing KO 304840

About PeopleBio, Inc.

http://www.peoplebio.net/en/PEOPLEBIO.p…

PeopleBio, Inc. is a biotechnology company specializing in the development and manufacturing of diagnostic products for protein misfolding diseases. The company's primary focus is on degenerative brain disorders, particularly Alzheimer's disease. It develops blood-based diagnostic kits and immunoassays designed for early detection. By providing tools for early diagnosis, PeopleBio aims to facilitate timely intervention and treatment, thereby improving patient outcomes for these conditions.

Recent filings

Filing Released Lang Actions
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by PeopleBio. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and articles of incorporation changes) for the upcoming Annual General Meeting. This type of document is classified as a Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to vote on meeting agenda items.
2022-03-11 Korean
주식매수선택권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the company 'PeopleBio' regarding the exercise of stock options (주식매수선택권행사). It details the number of shares exercised, the exercise price, the individuals involved (directors and employees), and the impact on total shares. This type of disclosure regarding the issuance of new shares resulting from stock option exercises is classified as a 'Share Issue/Capital Change' (SHA) in the provided taxonomy.
2022-03-10 Korean
전환가액의조정(제5회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the adjustment of the conversion price for convertible bonds (CB). It details the change in conversion price, the number of convertible shares, and the underlying reasons (market price decline). This falls under capital structure changes related to financing instruments, which is best classified as CAP (Capital/Financing Update).
2022-02-28 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (PeopleBio) regarding a 'Correction Report' (정정신고) for a previously disclosed 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details changes to the contract period and provides specific financial terms of the supply agreement. Since this is a specific regulatory disclosure regarding a material business contract and does not fit into categories like financial reports, board changes, or shareholder meetings, it is classified as a general regulatory filing.
2022-02-08 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (PeopleBio) regarding a significant change in financial structure (revenue or profit/loss change of 30% or more). This is a standard disclosure requirement in the Korean stock market (KRX) for listed companies to report material financial changes before the final audit is completed. Since it provides specific financial highlights and reasons for the change rather than just announcing the availability of a report, it falls under the category of an Earnings Release (ER) or a general regulatory filing. Given the specific nature of the financial data provided, 'ER' is the most accurate classification. FY 2021
2022-02-04 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling of an Investor Relations (IR) event (Non-Deal Roadshow). It provides details such as date, location, target audience, and purpose. Since it is an announcement of an upcoming event rather than the presentation materials themselves, and it does not fit into other specific categories like earnings releases or financial reports, it is classified as a general regulatory filing/announcement.
2022-01-21 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.